Metabolic modulation to improve MSC expansion and therapeutic potential for articular cartilage repair
Background Articular cartilage degeneration can result from injury, age, or arthritis, causing significant joint pain and disability without surgical intervention. Currently, the only FDA cell-based therapy for articular cartilage injury is Autologous Chondrocyte Implantation (ACI);...
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
BioMed Central
2024
|
Online Access: | https://hdl.handle.net/1721.1/156927 |